- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- December 2024
- 150 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- December 2024
- 368 Pages
Global
From €4434EUR$4,950USD£3,779GBP
- Report
- March 2025
- 325 Pages
Global
From €4434EUR$4,950USD£3,779GBP
- Report
- May 2025
- 193 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- March 2025
- 145 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 184 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 192 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- April 2025
- 250 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- May 2025
- 188 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- December 2024
- 150 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- July 2024
- 150 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- December 2024
- 100 Pages
United States
From €3538EUR$3,950USD£3,016GBP
- Report
- April 2024
- 325 Pages
Global
From €5282EUR$6,103USD£4,350GBP
From €2665EUR$2,975USD£2,271GBP
€3135EUR$3,500USD£2,672GBP
- Report
- August 2023
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- October 2021
- 102 Pages
Global
From €4031EUR$4,500USD£3,436GBP
- Report
- October 2024
- 150 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- October 2024
- 78 Pages
Global
From €3500EUR$4,186USD£3,088GBP

The Plaque Modification Device market is a subset of the Cardiovascular Devices market. It includes devices used to treat atherosclerosis, a condition in which plaque builds up in the arteries. These devices are used to reduce the risk of stroke, heart attack, and other cardiovascular diseases. Plaque Modification Devices can be divided into two categories: mechanical and pharmacological. Mechanical devices include atherectomy, angioplasty, and stenting. Pharmacological devices include drug-eluting stents and drug-coated balloons.
The Plaque Modification Device market is expected to grow due to increasing prevalence of cardiovascular diseases, technological advancements, and rising demand for minimally invasive treatments.
Some companies in the Plaque Modification Device market include Abbott, Boston Scientific, Medtronic, Terumo, and Biosensors International. Show Less Read more